NM_000814.6:c.240+2780G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000814.6(GABRB3):​c.240+2780G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.716 in 152,078 control chromosomes in the GnomAD database, including 39,062 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.72 ( 39062 hom., cov: 31)

Consequence

GABRB3
NM_000814.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.147

Publications

3 publications found
Variant links:
Genes affected
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000814.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
NM_000814.6
MANE Select
c.240+2780G>A
intron
N/ANP_000805.1
GABRB3
NM_021912.5
c.240+2780G>A
intron
N/ANP_068712.1
GABRB3
NM_001278631.2
c.-112+2780G>A
intron
N/ANP_001265560.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
ENST00000311550.10
TSL:1 MANE Select
c.240+2780G>A
intron
N/AENSP00000308725.5
GABRB3
ENST00000541819.6
TSL:1
c.408+2780G>A
intron
N/AENSP00000442408.2
GABRB3
ENST00000299267.9
TSL:1
c.240+2780G>A
intron
N/AENSP00000299267.4

Frequencies

GnomAD3 genomes
AF:
0.716
AC:
108738
AN:
151960
Hom.:
39025
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.719
Gnomad AMI
AF:
0.640
Gnomad AMR
AF:
0.594
Gnomad ASJ
AF:
0.800
Gnomad EAS
AF:
0.682
Gnomad SAS
AF:
0.745
Gnomad FIN
AF:
0.732
Gnomad MID
AF:
0.690
Gnomad NFE
AF:
0.736
Gnomad OTH
AF:
0.708
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.716
AC:
108825
AN:
152078
Hom.:
39062
Cov.:
31
AF XY:
0.712
AC XY:
52951
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.719
AC:
29825
AN:
41464
American (AMR)
AF:
0.594
AC:
9076
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.800
AC:
2776
AN:
3472
East Asian (EAS)
AF:
0.683
AC:
3521
AN:
5158
South Asian (SAS)
AF:
0.744
AC:
3586
AN:
4822
European-Finnish (FIN)
AF:
0.732
AC:
7749
AN:
10588
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.736
AC:
50004
AN:
67968
Other (OTH)
AF:
0.711
AC:
1502
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1547
3094
4642
6189
7736
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.727
Hom.:
6103
Bravo
AF:
0.704
Asia WGS
AF:
0.706
AC:
2452
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.4
DANN
Benign
0.83
PhyloP100
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212331; hg19: chr15-27014769; API